End-of-day quote
Dhaka S.E.
18:00:00 2024-06-11 EDT
|
5-day change
|
1st Jan Change
|
87.8
BDT
|
-0.45%
|
|
-1.13%
|
+4.03%
|
Fiscal Period: June |
2023
|
---|
Capitalization
1 |
12,546
|
Enterprise Value (EV)
1 |
16,267
|
P/E ratio
|
32.5
x
|
Yield
|
1.11%
|
Capitalization / Revenue
|
2.2
x
|
EV / Revenue
|
2.85
x
|
EV / EBITDA
|
18.4
x
|
EV / FCF
|
-6,738,086
x
|
FCF Yield
|
-0%
|
Price to Book
|
2.87
x
|
Nbr of stocks (in thousands)
|
107,416
|
Reference price
2 |
116.8
|
Announcement Date
|
12/5/23
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,149
|
3,607
|
4,759
|
5,706
|
EBITDA
1 |
314.5
|
397.7
|
675.4
|
882.2
|
EBIT
1 |
274.2
|
348.6
|
569.6
|
721.5
|
Operating Margin
|
8.71%
|
9.67%
|
11.97%
|
12.64%
|
Earnings before Tax (EBT)
1 |
219.3
|
302.4
|
391.8
|
449.1
|
Net income
1 |
137.4
|
202.3
|
274
|
356.9
|
Net margin
|
4.36%
|
5.61%
|
5.76%
|
6.26%
|
EPS
2 |
1.713
|
2.521
|
3.415
|
3.590
|
Free Cash Flow
|
-
|
-462.9
|
-1,687
|
-2,414
|
FCF margin
|
-
|
-12.84%
|
-35.46%
|
-42.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
1.100
|
1.300
|
Announcement Date
|
12/2/21
|
12/2/21
|
11/27/22
|
12/5/23
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
912
|
1,466
|
2,799
|
3,721
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.9
x
|
3.685
x
|
4.144
x
|
4.217
x
|
Free Cash Flow
|
-
|
-463
|
-1,687
|
-2,414
|
ROE (net income / shareholders' equity)
|
-
|
6.32%
|
8.07%
|
9.09%
|
ROA (Net income/ Total Assets)
|
-
|
4.51%
|
5.8%
|
5.41%
|
Assets
1 |
-
|
4,490
|
4,727
|
6,599
|
Book Value Per Share
2 |
38.70
|
41.20
|
43.40
|
40.70
|
Cash Flow per Share
2 |
0.6800
|
0.3200
|
0.8300
|
4.100
|
Capex
1 |
19.7
|
522
|
1,198
|
1,598
|
Capex / Sales
|
0.63%
|
14.47%
|
25.17%
|
28.01%
|
Announcement Date
|
12/2/21
|
12/2/21
|
11/27/22
|
12/5/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.03% | 80.53M | | +48.39% | 780B | | +41.76% | 627B | | +19.68% | 334B | | +6.81% | 296B | | +17.60% | 244B | | -0.41% | 217B | | +11.54% | 214B | | +4.23% | 161B | | -4.15% | 159B |
Other Pharmaceuticals
|